Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Evaxion Biotech AS (EVAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Evaxion Biotech AS's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.310 +0.090    +2.13%
16:00:29 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 30,941
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.190 - 4.410
Evaxion Biotech AS 4.310 +0.090 +2.13%

Evaxion Biotech AS Company Profile

 
Get an in-depth profile of Evaxion Biotech AS, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

63

Equity Type

DRC

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

Contact Information

Address Dr. Neergaards Vej 5th Floor
Horsholm, 2970
Denmark
Phone 45 53 53 18 50
Fax -

Top Executives

Name Age Since Title
Soren Brunak - - Member of Advisory Board
Robert J. Palay 67 - Member of Advisory Board
Jeffrey S. Weber - - Member of Advisory Board
Thomas Wylonis - - Member of Advisory Board
Roberto Prego Pineda 53 2018 Independent Director
Michael W. Washabaugh - - Member of Advisory Board
Lars Holtug 65 2021 Independent Director
Anthony Purcell - - Member of Advisory Board
Andrew C. Webber - - Member of Advisory Board
Rajeev Surati - - Member of Advisory Board
Jürgen Langhärig - 2019 Head of Business Development & Member of Advisory Board
Marianne Sogaard 56 2020 Independent Chairwoman of the Board
Georgina Long - - Member of Advisory Board
Niels Iversen Moller 45 2008 Co-Founder, VP of Business & Director
Patrick Ott - - Member of Advisory Board
Kirsten Aarup Drejer 68 2021 Member of Advisory Board
Christian Schilling - - Member of Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EVAX Comments

Write your thoughts about Evaxion Biotech AS
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jens Christiansen
Jens Christiansen Aug 07, 2022 2:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect it to go towards 5. Evax has finance in place and 2-3 products in their pipeline.
Jens Christiansen
Jens Christiansen Nov 05, 2021 1:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok. Make sense.
Batuhan Babür
Batuhan Babür Nov 05, 2021 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told you they filed for offering at 26 October and it was a pump before offering
Jens Christiansen
Jens Christiansen Nov 05, 2021 12:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why?
the elrushbo
theelrushbo Nov 05, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stock offering at $7.... should rebound quickly
Jens Christiansen
Jens Christiansen Nov 04, 2021 12:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have heard that it is short squeeze.
Jens Christiansen
Jens Christiansen Nov 04, 2021 9:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Neither can I. Strange.
Jacob McHaney
Jacob McHaney Nov 04, 2021 8:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cant find anything on why its up this much
Jens Christiansen
Jens Christiansen Nov 04, 2021 7:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is it up with 226%
Batuhan Babür
Batuhan Babür Nov 04, 2021 7:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They filed for offering at 26 October so I think a pump before offering occurs
Phat Khuu
Phat Khuu Nov 03, 2021 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Some good news?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email